EXHIBIT 10.10 AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc
INTRODUCTIONConsulting Agreement • November 1st, 2004 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Massachusetts
AS ISSUER,First Supplemental Indenture • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
COMMON STOCKUnderwriting Agreement • July 6th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.16 INDEMNFICATION AGREEMENT This Agreement, made and entered into this ___ day of June, 2000, ("Agreement"), by and between Charles River Laboratories International, Inc. a Delaware corporation ("Company"), and ______________...Indemnification Agreement • June 23rd, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
CHARLES RIVER LABORATORIES, INC. and CHARLES RIVER LABORATORIES HOLDINGS, INC. as Issuers $150,000,000 150,000 Units Consisting of 13 1/2% Senior Subordinated Notes due 2009 and Warrants to purchase 591,366 shares of Common StockPurchase Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
ANNEX I U.S. $156,100,000 AMENDED AND RESTATED CREDIT AGREEMENT, dated as of February 2, 2001 (amending and restating the Credit Agreement, dated as of September 29, 1999),Credit Agreement • February 15th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.4 CHARLES RIVER LABORATORIES, INC. 13 1/2% SENIOR SUBORDINATED NOTES DUE 2009 Guaranteed to the extent set forth herein by SBI HOLDINGS, INC. SIERRA BIOMEDICAL, INC. SIERRA BIOMEDICAL SAN DIEGO, INC.Indenture • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
EXHIBIT 10.4 JOINT VENTURE AGREEMENT THIS AGREEMENT, entered into this 24th day of June, 1981, between: AJINOMOTO CO., INC., a Japanese corporation having its principal place of business at 5-8, Kyobashi 1-chome, Chuo-ku, Tokyo, Japan (hereinafter...Joint Venture Agreement • April 25th, 2000 • Charles River Laboratories Holdings Inc • Blank checks
by and among Charles River Laboratories, Inc. as BuyerStock Purchase Agreement • February 15th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
DATED THE DAY OF 2002 --------------------------------------------------------- ----------------------- BETWEEN/ (1) THE PARTIES LISTED IN THE FIRST SCHEDULE (2) CHARLES RIVER EUROPE GMBH AND (3) CHARLES RIVER LABORATORIES INC. SHARE PURCHASE...Share Purchase Agreement • August 12th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances)
RECITALSAgreement and Plan of Reorganization • June 23rd, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
COMMON STOCKUnderwriting Agreement • March 15th, 2001 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 4.9 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 3 1/2% SENIOR CONVERTIBLE Debentures DUE 2022 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 1 TORecapitalization Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
Warrant AgentWarrant Agreement • December 8th, 1999 • Charles River Laboratories Holdings Inc • New York
ANNEX I AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AGREEMENT THIS AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AGREEMENT (this "AMENDMENT"), dated as of June 5, 2002, among Charles River Laboratories, Inc., a Delaware corporation (the...Credit Agreement • August 12th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 3 TO THE AMENDED AND RESTATED INVESTORS' AGREEMENTInvestors' Agreement • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.1 CREDIT AGREEMENT dated as of March 31, 2003Credit Agreement • May 5th, 2003 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee Subordinated Indenture Dated as of ____________ __, 20__Subordinated Indenture • May 9th, 2024 • Charles River Laboratories International, Inc. • Services-commercial physical & biological research • New York
SUBORDINATED INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank Trust Company, National Association, a national banking association, as Trustee.
WITNESSETH:Agreement and Release • June 6th, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as Issuer AND U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of June 12, 2006 2.25% Convertible Senior Notes due 2013Indenture • June 12th, 2006 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
INDENTURE dated as of June 12, 2006 between Charles River Laboratories International, Inc., a Delaware corporation, as issuer (hereinafter sometimes called the “Company”, as more fully set forth in Section 1.01), and U.S. Bank National Association, a national banking association organized under the laws of the United States, as trustee (hereinafter sometimes called the “Trustee”, as more fully set forth in Section 1.01).
PART II AMENDMENTS TO EXISTING CREDIT AGREEMENTCredit Agreement • May 9th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee ___________________________________ Senior Indenture Dated as of ______ __, 20__ ___________________________________Senior Indenture • May 9th, 2024 • Charles River Laboratories International, Inc. • Services-commercial physical & biological research • New York
SENIOR INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank Trust Company, National Association, a national banking association, as Trustee.
SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 30, 2016 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF...Credit Agreement • April 5th, 2016 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
SEVENTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 30, 2016, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrowers party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as the Company and U.S. BANK NATIONAL ASSOCIATION as TrusteeSubordinated Indenture • May 9th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
SUBORDINATED INDENTURE, dated as of ______ __, 20__, between Charles River Laboratories International, Inc., a Delaware corporation, as the Company, and U.S. Bank National Association, a national banking association, as Trustee.
FOURTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of September 23, 2011 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrower Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent, BANK...Credit Agreement • September 23rd, 2011 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
FOURTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of September 23, 2011, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrower party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
CHARLES RIVER LABORATORIES Severance AgreementSeverance Agreement • June 6th, 2000 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances)
EIGHTH AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 26, 2018 among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., The Subsidiary Borrowers Party Hereto, The Lenders Party Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BanK of...Credit Agreement • March 26th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • New York
EIGHTH AMENDED AND RESTATED CREDIT AGREEMENT, dated as of March 26, 2018, among CHARLES RIVER LABORATORIES INTERNATIONAL, INC., the Subsidiary Borrowers party hereto, the Lenders party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
FORM OF CHARLES RIVER LABORATORIES INTERNATIONAL, INC. PERFORMANCE SHARE UNIT AWARD AGREEMENT (the “Award Agreement”)Performance Share Unit Award Agreement • August 5th, 2020 • Charles River Laboratories International, Inc. • Services-commercial physical & biological research • Delaware
This Performance Share Unit Award (the “Award”) is granted as of May 29, 2020 by Charles River Laboratories International, Inc. (the “Company”) to «FN_» «LN_» (the “Participant”) on the terms and conditions as set forth in this Award Agreement and in the 2018 Incentive Plan (as amended from time to time, the “Plan”). All capitalized terms used herein shall have the meaning specified in the Plan, unless another meaning is specified herein.
AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT AND AMENDMENT NO. 1 TO AMENDED AND RESTATED HOLDCO GUARANTY AND PLEDGE AGREEMENTCredit Agreement • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 99.7 August 13, 2004 Charles River Laboratories International, Inc. 251 Ballardvale Street Wilmington, Massachusetts 01887 Re: Registration Statement on Form S-4 Ladies and Gentlemen: Reference is hereby made to the Agreement and Plan of...Merger Agreement • August 16th, 2004 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances)
AGREEMENT AND PLAN OF MERGER BY AND AMONG Charles River Laboratories INTERNATIONAL, INC. Forest Acquisition Corporation, ACP MOUNTAIN HOLDINGS, INC. and AVISTA CAPITAL PARTNERS IV GP, LP, solely in its capacity as the Stockholders’ Representative...Merger Agreement • February 13th, 2018 • Charles River Laboratories International Inc • Services-commercial physical & biological research • Delaware
This AGREEMENT AND PLAN OF MERGER, dated February 12, 2018 (this “Agreement”), is made and entered into by and among Charles River Laboratories International, Inc., a Delaware corporation (“Buyer”), Forest Acquisition Corporation, a Delaware corporation and a direct or indirect wholly-owned Subsidiary of Buyer or its Affiliates (“Merger Sub”), ACP Mountain Holdings, Inc., a Delaware corporation (the “Company”), and, solely in its capacity as the Stockholders’ Representative pursuant to Section 10.16 hereof, Avista Capital Partners GP, LP, a Delaware limited partnership (the “Stockholders’ Representative”). Buyer, Merger Sub, the Company and the Stockholders’ Representative (solely for purposes of Section 10.16) are sometimes individually referred to in this Agreement as a “Party” and collectively as the “Parties”. Capitalized terms used in this Agreement shall have the meanings ascribed to them in Exhibit A attached hereto.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. as Issuer EACH OF THE GUARANTORS PARTY HERETO as Guarantors U.S. BANK NATIONAL ASSOCIATION as Trustee First Supplemental Indenture Dated as of March 23, 2021 to the Indenture dated as of March 23, 2021...First Supplemental Indenture • March 23rd, 2021 • Charles River Laboratories International, Inc. • Services-commercial physical & biological research • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March 23, 2021, among Charles River Laboratories International, Inc., a Delaware corporation (the “Company”), the Guarantors listed on Schedule A hereto (the “Guarantors”) and U.S. Bank National Association (the “Trustee”), as trustee under the Indenture, dated as of March 23, 2021, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).
TERMINATION AGREEMENTTermination Agreement • July 30th, 2010 • Charles River Laboratories International Inc • Services-commercial physical & biological research • Delaware
TERMINATION AGREEMENT, dated as of July 29, 2010 (this “Agreement”), between WuXi PharmaTech (Cayman) Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands (“WuXi”), and Charles River Laboratories International, Inc., a Delaware corporation (“Charles River”).
